We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Three Fetal Trisomies Detected by Noninvasive LDT

By LabMedica International staff writers
Posted on 09 Feb 2012
A laboratory-developed test (LDT) can detect fetal trisomy 21, 18, and 13 with high accuracy from a maternal blood sample.

The noninvasive test is a laboratory-developed test (LDT) that analyzes circulating cell-free DNA extracted from a maternal blood sample. More...
It was developed by Sequenom Center for Molecular Medicine (SCMM; Grand Rapids, MI, USA), a life sciences company that provides genetic analysis solutions.

A large international, multicenter study was conducted at 27 prenatal diagnostic centers in the United States to validate the test. Scientists collected and processed maternal plasma samples from 4,664 pregnant women at high risk for fetal aneuploidy undergoing diagnostic testing in the late first and early second trimester.

A total of 62 trisomy 18 and 12 trisomy 13 pregnancies along with their matched controls were tested using the MaterniT21 LDT. When unblinded, the detection rate for trisomy 18 was 100% and for trisomy 13, was 91.7 %, with false positive rates of 0.28 and 0.97 percent, respectively.

The MaterniT21 test is available exclusively through Sequenom CMM as a testing service to physicians.

The study appeared on February 2, 2012 in the online issue of Genetics in Medicine.

Sequenom Center for Molecular Medicine (Sequenom CMM), a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified molecular diagnostics laboratory, is developing a broad range of diagnostics with a focus on prenatal diseases and conditions. These laboratory-developed tests provide beneficial patient management options for obstetricians, geneticists, and maternal fetal medicine specialists.

Related Links:
Sequenom Center for Molecular Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.